SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-027474
Filing Date
2017-05-15
Accepted
2017-05-15 16:15:09
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v465964_10q.htm 10-Q 357496
2 EXHIBIT 31.1 v465964_ex31-1.htm EX-31.1 9921
3 EXHIBIT 31.2 v465964_ex31-2.htm EX-31.2 10075
4 EXHIBIT 32.1 v465964_ex32-1.htm EX-32.1 4777
  Complete submission text file 0001144204-17-027474.txt   3042202

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mtnb-20170331.xml EX-101.INS 570909
6 XBRL TAXONOMY EXTENSION SCHEMA mtnb-20170331.xsd EX-101.SCH 34052
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtnb-20170331_cal.xml EX-101.CAL 24587
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtnb-20170331_def.xml EX-101.DEF 212137
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtnb-20170331_lab.xml EX-101.LAB 245565
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtnb-20170331_pre.xml EX-101.PRE 244011
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 17844366
SIC: 2834 Pharmaceutical Preparations